85 related articles for article (PubMed ID: 15763944)
1. Angiopoietin-1 inhibits doxorubicin-induced human umbilical vein endothelial cell death by modulating fas expression and via the PI3K/Akt pathway.
Yin D; Li C; Kao RL; Ha T; Krishnaswamy G; Fitzgerald M; Stuart CA
Endothelium; 2004; 11(5-6):247-52. PubMed ID: 15763944
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells.
Harfouche R; Hasséssian HM; Guo Y; Faivre V; Srikant CB; Yancopoulos GD; Hussain SN
Microvasc Res; 2002 Jul; 64(1):135-47. PubMed ID: 12074640
[TBL] [Abstract][Full Text] [Related]
3. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling.
Wang Z; Jiang C; Ganther H; Lü J
Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751
[TBL] [Abstract][Full Text] [Related]
4. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.
Secchiero P; Gonelli A; Carnevale E; Milani D; Pandolfi A; Zella D; Zauli G
Circulation; 2003 May; 107(17):2250-6. PubMed ID: 12668516
[TBL] [Abstract][Full Text] [Related]
5. RANKL regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway.
Kim HH; Shin HS; Kwak HJ; Ahn KY; Kim JH; Lee HJ; Lee MS; Lee ZH; Koh GY
FASEB J; 2003 Nov; 17(14):2163-5. PubMed ID: 14500543
[TBL] [Abstract][Full Text] [Related]
6. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 modulates Fas (APO-1/CD95)-mediated apoptosis of human pre-B cell lines.
Lanvin O; Guglielmi P; Fuentes V; Gouilleux-Gruart V; Mazière C; Bissac E; Regnier A; Benlagha K; Gouilleux F; Lassoued K
Eur J Immunol; 2003 May; 33(5):1372-81. PubMed ID: 12731064
[TBL] [Abstract][Full Text] [Related]
8. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL).
Rychahou PG; Murillo CA; Evers BM
Surgery; 2005 Aug; 138(2):391-7. PubMed ID: 16153452
[TBL] [Abstract][Full Text] [Related]
9. MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavage.
Bild AH; Mendoza FJ; Gibson EM; Huang M; Villanueva J; Garrington TP; Jove R; Johnson GL; Gibson SB
Oncogene; 2002 Sep; 21(43):6649-56. PubMed ID: 12242663
[TBL] [Abstract][Full Text] [Related]
10. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
Moriyama H; Yonehara S
Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt.
Schulze-Bergkamen H; Brenner D; Krueger A; Suess D; Fas SC; Frey CR; Dax A; Zink D; Büchler P; Müller M; Krammer PH
Hepatology; 2004 Mar; 39(3):645-54. PubMed ID: 14999683
[TBL] [Abstract][Full Text] [Related]
12. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells.
Jin YP; Fishbein MC; Said JW; Jindra PT; Rajalingam R; Rozengurt E; Reed EF
Hum Immunol; 2004 Apr; 65(4):291-302. PubMed ID: 15120184
[TBL] [Abstract][Full Text] [Related]
13. A synthetic naringenin derivative, 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), induces apoptosis through up-regulation of Fas/FasL expression and inhibition of PI3K/Akt signaling pathways in non-small-cell lung cancer cells.
Bak Y; Kim H; Kang JW; Lee DH; Kim MS; Park YS; Kim JH; Jung KY; Lim Y; Hong J; Yoon DY
J Agric Food Chem; 2011 Sep; 59(18):10286-97. PubMed ID: 21877710
[TBL] [Abstract][Full Text] [Related]
14. Urotensin II inhibits doxorubicin-induced human umbilical vein endothelial cell death by modulating ATF expression and via the ERK and Akt pathway.
Chen YL; Tsai YT; Lee CY; Lee CH; Chen CY; Liu CM; Chen JJ; Loh SH; Tsai CS
PLoS One; 2014; 9(9):e106812. PubMed ID: 25268131
[TBL] [Abstract][Full Text] [Related]
15. FasL/Fas pathway is involved in dengue virus induced apoptosis of the vascular endothelial cells.
Liao H; Xu J; Huang J
J Med Virol; 2010 Aug; 82(8):1392-9. PubMed ID: 20572077
[TBL] [Abstract][Full Text] [Related]
16. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
17. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
[TBL] [Abstract][Full Text] [Related]
19. Fas signaling induces Akt activation and upregulation of endothelial nitric oxide synthase expression.
Takemura Y; Fukuo K; Yasuda O; Inoue T; Inomata N; Yokoi T; Kawamoto H; Suhara T; Ogihara T
Hypertension; 2004 Apr; 43(4):880-4. PubMed ID: 14967838
[TBL] [Abstract][Full Text] [Related]
20. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B.
Montaner S; Sodhi A; Pece S; Mesri EA; Gutkind JS
Cancer Res; 2001 Mar; 61(6):2641-8. PubMed ID: 11289142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
